Portola Pharmaceuticals   Print Page    Close Window

Where is Portola Pharmaceuticals located?
Portola’s corporate offices are located at:
Portola Pharmaceuticals Inc.
270 E. Grand Avenue, South San Francisco, CA 94080

When was Portola Pharmaceuticals founded?
Portola was incorporated in the State of Delaware in 2003.

How many employees does Portola Pharmaceuticals have?
Portola has approximately 320 employees.

On what stock exchange and under what symbol are Portola Pharmaceuticals’ shares traded?
Portola Pharmaceuticals is listed on the NASDAQ Global Market under the symbol PTLA.

How can I buy and sell shares of Portola Pharmaceuticals’ stock?
Portola does not offer a direct purchase plan for investors. You may purchase Portola's stock through a licensed securities broker.

Who is Portola Pharmaceuticals transfer agent?
Our transfer agent is:
American Stock Transfer
Address: One Embarcadero Center - Suite 530, San Francisco, CA 94111
Phone Number 415.835.1313

Who do I contact regarding lost stock certificates, address changes, and changes of ownership or name in which shares are held?
Please contact our transfer agent:
American Stock Transfer
Address: One Embarcadero Center - Suite 530, San Francisco, CA 94111
Phone Number 415.835.1313

Does Portola Pharmaceuticals issue dividends on its common stock?
Portola does not pay cash dividends on its common stock and does not anticipate doing so in the foreseeable future.

Who are Portola Pharmaceuticals’ independent auditors?
Our independent auditors are:
Ernst & Young LLP
Address: Suite 600, 275 Shoreline Drive, Redwood City, CA 94065
Phone Number: 650.802.4500

Who is Portola Pharmaceuticals outside legal counsel?
Our outside legal counsel is:
Cooley LLP
Address: 3175 Hanover Street, Palo Alto, CA 94304
Phone Number: 650.843.5000

When is Portola Pharmaceuticals' fiscal year end?
Our fiscal year end is December 31.

How can I contact Portola Pharmaceuticals regarding Investor Relations issues?
Please email IR@portola.com for assistance with Investor Relations questions.